<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Clin Cancer Res</journal-id>
        <journal-id journal-id-type="iso-abbrev">Clin Cancer Res</journal-id>
        <journal-id journal-id-type="pmc-domain-id">319</journal-id>
        <journal-id journal-id-type="pmc-domain">nihpa</journal-id>
        <journal-title-group>
          <journal-title>Clinical cancer research : an official journal of the American Association for Cancer Research</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">1078-0432</issn>
        <issn pub-type="epub">1557-3265</issn>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-is-collection-domain</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-collection-title</meta-name>
            <meta-value>NIHPA Author Manuscripts</meta-value>
          </custom-meta>
        </custom-meta-group>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC9197876</article-id>
        <article-id pub-id-type="pmcid-ver">PMC9197876.1</article-id>
        <article-id pub-id-type="pmcaid">9197876</article-id>
        <article-id pub-id-type="pmcaiid">9197876</article-id>
        <article-id pub-id-type="manuscript-id">NIHMS1797725</article-id>
        <article-id pub-id-type="pmid">35377946</article-id>
        <article-id pub-id-type="doi">10.1158/1078-0432.CCR-21-4016</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHMS1797725</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHPA1797725</article-id>
        <article-version article-version-type="pmc-version">1</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Article</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Sihag</surname>
              <given-names initials="S">Smita</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="CR1" ref-type="corresp">*</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Nussenzweig</surname>
              <given-names initials="SC">Samuel C.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Walch</surname>
              <given-names initials="HS">Henry S.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Hsu</surname>
              <given-names initials="M">Meier</given-names>
            </name>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Tan</surname>
              <given-names initials="KS">Kay See</given-names>
            </name>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>De La Torre</surname>
              <given-names initials="S">Sergio</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Janjigian</surname>
              <given-names initials="YY">Yelena Y.</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Maron</surname>
              <given-names initials="SB">Steven B.</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ku</surname>
              <given-names initials="GY">Geoffrey Y.</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Tang</surname>
              <given-names initials="LH">Laura H.</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Shah</surname>
              <given-names initials="PM">Pari M.</given-names>
            </name>
            <xref rid="A6" ref-type="aff">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Wu</surname>
              <given-names initials="A">Abraham</given-names>
            </name>
            <xref rid="A7" ref-type="aff">7</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Jones</surname>
              <given-names initials="DR">David R.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Solit</surname>
              <given-names initials="DB">David B.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Schultz</surname>
              <given-names initials="N">Nikolaus</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ganesh</surname>
              <given-names initials="K">Karuna</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Berger</surname>
              <given-names initials="MF">Michael F.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Molena</surname>
              <given-names initials="D">Daniela</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="CR1" ref-type="corresp">*</xref>
          </contrib>
        </contrib-group>
        <aff id="A1"><label>1</label>Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065</aff>
        <aff id="A2"><label>2</label>Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065</aff>
        <aff id="A3"><label>3</label>Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065</aff>
        <aff id="A4"><label>4</label>Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065</aff>
        <aff id="A5"><label>5</label>Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065</aff>
        <aff id="A6"><label>6</label>Department of Gastroenterology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065</aff>
        <aff id="A7"><label>7</label>Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065</aff>
        <author-notes>
          <corresp id="CR1"><label>*</label><bold>Co-Corresponding Authors:</bold> Daniela Molena, M.D. 1275 York Avenue, Office C878, New York, NY 10065, 212-639-3970, <email>molenad@mskcc.org</email>, Smita Sihag, M.D., M.P.H. 1275 York Avenue, Office C881, New York, NY 10065, 212-639-3309, <email>sihags@mskcc.org</email></corresp>
          <fn fn-type="COI-statement" id="FN1">
            <p id="P40"><bold>Conflicts of interest:</bold> All other authors have no conflicts to report.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="ppub">
          <day>13</day>
          <month>6</month>
          <year>2022</year>
        </pub-date>
        <volume>28</volume>
        <issue>12</issue>
        <issue-id pub-id-type="pmc-issue-id">410228</issue-id>
        <fpage>2669</fpage>
        <lpage>2678</lpage>
        <pub-history>
          <event event-type="nihms-submitted">
            <date>
              <day>11</day>
              <month>05</month>
              <year>2022</year>
            </date>
          </event>
          <event event-type="pmc-release">
            <date>
              <day>13</day>
              <month>12</month>
              <year>2022</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>13</day>
              <month>12</month>
              <year>2022</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2024-06-13 13:25:16.590">
              <day>13</day>
              <month>06</month>
              <year>2024</year>
            </date>
          </event>
        </pub-history>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1797725.pdf"/>
        <abstract id="ABS1">
          <sec id="S1">
            <title>Purpose:</title>
            <p id="P1">In patients with locally advanced esophageal adenocarcinoma (EAC), response to neoadjuvant therapy strongly predicts survival, but robust molecular predictors of response have been lacking. We therefore sought to discover meaningful predictors of response in these patients.</p>
          </sec>
          <sec id="S2">
            <title>Experimental Design:</title>
            <p id="P2">We retrospectively identified all patients with adenocarcinoma of the lower esophagus or gastroesophageal junction who (1) were treated with multimodality therapy with curative intent at our institution from 2014 through 2020 and (2) underwent prospective sequencing by MSK-IMPACT. Clinicopathologic and genomic data were analyzed to identify potential genomic features, somatic alterations, and oncogenic pathways associated with treatment response.</p>
          </sec>
          <sec id="S3">
            <title>Results:</title>
            <p id="P3">In total, 237 patients were included. MDM2 amplification was independently associated with poor response to neoadjuvant therapy [OR 0.10 (95% CI 0.01, 0.55); p=0.032], when accounting for significant clinicopathologic variables, including clinical stage, tumor grade, and chemotherapy regimen. Moreover, TP53 pathway alterations, grouped according to inferred severity of TP53 dysfunction, were significantly associated with response to neoadjuvant therapy (p=0.004, q=0.07). Patients with MDM2 amplifications or truncating bi-allelic TP53 mutations had similar outcomes in terms of poor responses to neoadjuvant therapy and, consequently, shorter progression-free survival, compared with patients with TP53 pathway wild-type tumors. Thus, worsening TP53 dysfunction was directly correlated with worse outcomes.</p>
          </sec>
          <sec id="S4">
            <title>Conclusions:</title>
            <p id="P4">MDM2 amplification and TP53 status are associated with response to therapy in patients with EAC. Given the dearth of actionable targets in EAC, MDM2 inhibition, in combination with cytotoxic chemotherapy, may represent an important therapeutic strategy to overcome treatment resistance and improve outcomes in these patients.</p>
          </sec>
        </abstract>
        <kwd-group>
          <kwd>p53</kwd>
          <kwd>MDM2</kwd>
          <kwd>esophageal cancer</kwd>
          <kwd>neoadjuvant therapy</kwd>
        </kwd-group>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
  </article>
</pmc-articleset>
